Alievio
Stage
Loan | AliveTotal Raised
$8.04MLast Raised
$250K | 3 yrs agoAbout Alievio
Alievio fka Camras Vision is an ophthalmic medical device company developing a new technology for the 67 million glaucoma sufferers. Ophthalmologists are faced with limited surgical treatments due to their instability and unpredictability in controlling glaucoma. As a result, 1 out of 10 patients still lose their vision even when properly treated. Alievio wishes to address these problems with their device, the Camras Shunt. The Camras Shunt is a device that provides the first-ever personalized pressure control to attain the highest level of efficacy in stopping glaucoma progression.
Missing: Alievio's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Alievio's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Alievio
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Alievio is included in 2 Expert Collections, including Medical Devices.
Medical Devices
8,633 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health IT
7,901 items
Alievio Patents
Alievio has filed 8 patents.
The 3 most popular patent topics include:
- Diseases of the eye and adnexa
- Eye surgery
- Glaucoma
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
9/30/2015 | 1/7/2020 | Diseases of the eye and adnexa, Ophthalmology, Eye surgery, Disorders of sclera and cornea, Glaucoma | Grant |
Application Date | 9/30/2015 |
|---|---|
Grant Date | 1/7/2020 |
Title | |
Related Topics | Diseases of the eye and adnexa, Ophthalmology, Eye surgery, Disorders of sclera and cornea, Glaucoma |
Status | Grant |
Latest Alievio News
Jun 12, 2019
. News provided by Share this article RESEARCH TRIANGLE PARK, N.C., June 12, 2019 /PRNewswire/ -- Alievio , a medical device company formerly known as Camras Vision, announced its name change today as part of a rebranding effort to further position the company as a leader in innovative glaucoma treatment solutions. Ray Krauss, Chief Executive Officer at Alievio, said, "It has long been our mission to help patients who suffer from this debilitating disease preserve what precious vision they still have and enjoy a higher quality of life." The name Alievio highlights the mission of the company, to alleviate and provide a sense of relief to those patients suffering from late-stage glaucoma, instilling a sense of hope and optimism of retaining their remaining vision through a new and innovative glaucoma treatment option. The rebranding includes a newly designed website, logo and communication assets. Alievio's new logo is meant to express the high level of technology and science that is behind the design of the device, conveying the company's target to be at the forefront of innovation in the glaucoma treatment space. The website affords the reader a thorough background on general glaucoma education and outlines how Alievio's device meets a significant unmet need in lowering intraocular pressure (IOP), in comparison to current technologies and treatment options in the space. As Alievio's device progresses towards commercialization, the company intends to generate awareness about glaucoma treatment for those late-stage patients who have failed to find relief and slow the progression of the disease with existing treatment options. Contact Info
Alievio Frequently Asked Questions (FAQ)
Where is Alievio's headquarters?
Alievio's headquarters is located at 2 Davis Drive, Durham.
What is Alievio's latest funding round?
Alievio's latest funding round is Loan.
How much did Alievio raise?
Alievio raised a total of $8.04M.
Who are the investors of Alievio?
Investors of Alievio include Paycheck Protection Program, Triangle Angel Partners, IMAF Coastal Plain, Triangle Venture Alliance, VCapital Management and 5 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.